TriSalus Life Sciences Inc
NASDAQ:TLSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TriSalus Life Sciences Inc
NASDAQ:TLSI
|
US |
|
S Chand and Company Ltd
NSE:SCHAND
|
IN |
|
A
|
Aether Holdings Inc
NASDAQ:ATHR
|
US |
|
Mercia Asset Management PLC
LSE:MERC
|
UK |
|
F
|
Freemelt Holding AB (publ)
STO:FREEM
|
SE |
|
Solocal Group SE
F:QS30
|
FR |
|
C
|
China Life Insurance Co Ltd
F:CHL
|
CN |
|
Grupo Rotoplas SAB de CV
OTC:GRPRF
|
MX |
|
Klepierre SA
PAR:LI
|
FR |
|
Diversified Royalty Corp
TSX:DIV
|
CA |
|
Arix Bioscience PLC
LSE:ARIX
|
UK |
|
Takamatsu Construction Group Co Ltd
TSE:1762
|
JP |
Wall St Price Targets
TLSI Price Targets Summary
TriSalus Life Sciences Inc
According to Wall Street analysts, the average 1-year price target for TLSI is 8.98 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TLSI's stock price target?
Price Target
8.98
USD
According to Wall Street analysts, the average 1-year price target for TLSI is 8.98 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.
What is the Revenue forecast for TriSalus Life Sciences Inc?
Projected CAGR
26%
The compound annual growth rate for Revenue over the next 8 years is 26%.